Fair Square Medicare is a tech-enabled senior concierge healthcare platform. Today, they announced $15 million in Series B funding. Define Ventures led the round with participation from Slow Ventures and YCombinator (YC), as well as angel investors. To date, the company has raised $19 Million. [Read more…]

Today, the American Council of Cannabis Medicine announced that they have selected and participated in the NHCSA Building Bridges Program. To foster understanding and provide resources to the health care sharing sector and its millions of members throughout the country. [Read more…]

Numinus Wellness Inc. (“Numinus”, the “Company”) (TSX: NUMI) (OTCQX: NUMIF) is pleased to announce the acquisition (the “Transaction”) of Novamind Inc. (“Novamind”) has completed, following Novamind’s receipt of a final order from the BC Supreme Court. As a result of the acquisition, Numinus now operates 13 wellness clinics, four clinical research facilities and a dedicated psychedelics research lab – positioning the company as a leading integrated mental wellness company providing ketamine- and psychedelic-assisted therapies. [Read more…]

NRx Pharmaceuticals, Inc., (Nasdaq : NRXP, NRx Pharmaceuticals), a clinical-stage biopharmaceutical firm, announced today that the U.S. Food and Drug Administration denied the Breakthrough Therapy designation (BTD). The FDA denied ZYESAMI (r) (aviptadil). It emphasized the company’s NRX101 BTD compound for Bipolar Disorder associated with Suicidality and its NRX-101 BTD drug. Based on the positive findings of a subgroup analysis of patients treated with Aviptadil and placebo, and who had respiratory failure due to Critical COVID-19, the request for BTD was made. [Read more…]

King Insurance (or the “Company”), is a fast-growing, full-service brokerage that offers a wide range of property and casualty insurance products as well as employee benefit solutions. Today, King Insurance announced the acquisition of The Wurzel Agency, Inc. (“Wurzel Insurance”) [Read more…]

eHealth, Inc. (NASDAQ : EHTH) released results from a survey involving more than 2,800 Medicare beneficiaries. The survey explored their satisfaction with their Medicare Advantage plans. [Read more…]

Curated mental Health, P.L.L.C., an innovative psychiatry practice in New York City, announced today they have entered into an agreement to partner Brooklyn Minds Psychiatry, P.C., and Mind Centers, Inc., its associated management services organization. [Read more…]

WorXsiteHR has teamed up to offer employees a completely free medical plan called HealthWorX. This is in order to help US businesses and employees regain lost revenues and address new hiring and retention problems. [Read more…]

RazorMetrics’ recent survey of consumers about drug costs revealed some unexpected results. Healthcare consumers still want their doctor to lead, despite the rise in savings apps driven by consumers. According to the survey, 80% of respondents said they would prefer that their doctor choose a lower-cost drug for them and make it happen automatically. [Read more…]

The Frontiers of Digital Health is the premier open access publication on digital health. It features a new approach to personalized behavioral interventions for historically underserved communities. Kelsey Lynett Ford (DrPH) and Ashley B. authored the program and article that showcase an innovative perspective on behavioral design and equity. The case study from COVID-19 vaccine illustrates this point. West, PhD; Amy Bucher, PhD; and Chandra Y. Osborn, PhD. [Read more…]

Braxia Scientific Corp. (CSE: BRAXF (OTC: BRAXF (FWB: 4996), a medical research firm with clinics that provide innovative ketamine treatments to people with depression and other disorders, provided today an update on its leading research role in the psychedelics sector. Braxia Scientific’s research team continues to develop innovative treatments for depression. This includes potential ketamine derivatives. Braxia Scientific also continues to conduct multiple psychedelic-based clinical trials. This adds to the Company’s growing proprietary data that will be used to inform future drug development. [Read more…]

After decades of legal scrutiny, psychedelics such as MDMA and psilocybin were granted a stamp by Health Canada for medical purposes. The Canadian legislation allows the use of psychedelics for medical purposes beyond palliative care. This is a significant breakthrough for health professionals and advocates calling it a major step forward in the treatment of serious or life-threatening conditions. This is a great news for patients who are interested in psychedelic treatment for mental illness. It will also offer Compass Pathways (NASDAQ CMPS), ATAI Life Sciences, NASDAQ:ATAI), Revive Therapeutics Ltd.(OTCQB:RVVTF), Mind Medicine/MindMed (NASDAQ :MNMD), (NEO:MMED), Numinus Wellness (TSX :NUMI), (OTCPK :NUMIF), which are currently conducting clinical trials on various psychedelics) a smoother path to approval. [Read more…]

Braxia Scientific Corp. (CSE: BRAXF (OTC: BRAXF (FWB: 4996), a medical research firm with clinics that provide innovative ketamine treatments to people with depression and other disorders, recently provided an update on its leading research role in the psychedelics sector. Braxia Scientific’s research team continues to develop innovative treatments for depression. This includes potential ketamine derivatives. Braxia Scientific also continues to conduct multiple psychedelic-based clinical trials. This adds to the Company’s growing proprietary data that will be used to inform future drug development. [Read more…]

The American College of Emergency Physicians and the American College of Radiology (ACR) brought a lawsuit against federal government. The lawsuit claimed that the interim final ruling (IFR), on surprise medical billing, goes against the No Surprises Act language and will ultimately hurt patients and access to care. [Read more…]

As a token of appreciation for Spectrum Health employees’ dedication to caring for the community during the COVID-19 epidemic, Meridian Health Plan of Michigan and Apple Spice Catering Company teamed up to deliver 900 boxes lunches to Spectrum Health employees. [Read more…]

Psilocybin and ketamine, which is the active ingredient of magic mushrooms, are promising drugs for treating mental disorders. Psychoedelic-assisted therapy clinics are becoming more focused on the patient experience, and not just the use of ketamine or other psychedelic drugs therapies. The therapy is being seen as a part of the overall experience and not the final word. Experts believe that this new direction, which combines digital mental health therapy and psychedelics with other mind-altering substances, can lower the cost of care and improve patient outcomes and protocols. [Read more…]

Douglas Pharmaceuticals Ltd (Douglas), a privately held New Zealand-headquartered pharmaceutical company, today announced positive top-line data from its multinational, randomized, placebo-controlled, double-blind Phase 2 study of R-107 designed to investigate the efficacy and safety of R-107 (ketamine 30, 60, 120 or 180 mg) versus placebo for TRD. The study was carried out in New Zealand and Australia, Singapore, Taiwan, and 2021. 168 patients were randomized. [Read more…]

The Emergency Department Practice Management Association (EDPMA), an organization representing the practice of Emergency Medicine, filed an amicus brief, along with Texas ACEP and Virginia ACEP, in support of the Texas Medical Association’s and Dr. Adam Corley’s lawsuit against four federal agencies challenging the legality of an interim final rule issued in September implementing dispute resolution in the No Surprises Act (Rule). [Read more…]

Sensely, a virtual assistant pioneer, announced a partnership with Krungthai AXA Life Insurance. This Thai-based carrier provides health insurance to around 500,000 members. Krungthai AXA Life, a Thai-based carrier that provides health insurance to approximately 500,000 members, has incorporated Sensely’s technology into its Emma application. This powerful digital solution offers policyholders access to a variety of healthcare services and policy information through one application. [Read more…]

Osigu is the most trusted real-time claims and e-prescription platform for Latin America. It announced today that it has secured $7.5 Million in a new round led by IDC Ventures. Jose Vargas, cofounder of Healthcare.com (a leading digital insurance company), was also involved. This funding will allow Osigu to expand into Colombian markets and improve its ML algorithms, AI features, as well as expand Osigu’s reach. [Read more…]

Servatus Ltd is an unlisted Australian biopharmaceutical firm and global expert in the development and identification of new autoimmune therapies using live microbial biotherapeutics. It has received strong support from its sophisticated shareholders. [Read more…]

NeuroSense Therapeutics Limited. is a clinical-stage biotechnology firm that focuses on developing and discovering treatments for neurodegenerative diseases such as ALS, Alzheimer’s, and Parkinson’s. It today announced pricing for its initial public offering. Each unit consists of one ordinary share and a warrant that allows the right to purchase one share at $6.00 per share. This will generate gross proceeds of $12,000,000. NeuroSense also granted the underwriter a 45 day option to purchase an additional 300,000 ordinary shares and/or 300,000. warrants at the initial price. This is in addition to the underwriting discounts, commissions, and underwriting commissions. NeuroSense’s warrants and ordinary shares have been approved to be listed on the Nasdaq Capital Market. They are expected to trade on December 9, 2021, under the ticker symbols “NRSNW” and “NRSNW.” [Read more…]

Radius Health, Inc. (“Radius”) and Menarini Group (“Menarini”) shared details about the elacestrant data of the EMERALD study. These results were presented at the San Antonio Breast Cancer Symposium. The data was presented by Dr. Aditya Barhia, MD as a “Late Breaker”, and shared in an oral presentation. [Read more…]

Today, the Muscular Dystrophy Association, I AM ALS and the ALS Association issued the following statement regarding today’s passage of ACT For ALS in Congress: [Read more…]

CB Intelligence today introduced Jasper Health, an intelligent platform that offers care guidance and navigation to people with cancer, at its third annual Digital Health150 event. This event showcases 150 of the most promising private digital healthcare companies around the globe. CB Insights’ annual Future of Health event featured the unveiling of Digital Health 150 for 2015. [Read more…]

TruHearing and Fidelity Security Life Insurance Company have partnered to create a hearing insurance plan. This will allow benefits professionals to offer hearing benefits as an additional offering similar to vision and dental. TruHearing’s strategic partnership with Fidelity Security Life Insurance Companysup>(r) will allow for increased access to hearing benefits for employees, unions, and public sector groups. It also raises awareness about the importance of hearing care. The plan offers health insurance coverage through fixed indemnity benefits that cover hearing exams and hearing aids. The premium can be paid by an employee or the employer. You can either use it as a standalone benefit or combine it with other benefits. [Read more…]

Gravie was named to Inc. 2021 Best in Business List in the Insurance category at the gold medal level. Inc.’s Best in Business Awards recognizes 147 companies who have made a significant impact on society. Gravie, a health benefits company that makes it easier for people to access and purchase healthcare, was also included in the accompanying article: “A Health Insurance Plan That You Won’t Hate?” This is the Mission of This Company. ” [Read more…]